{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:05:09Z","timestamp":1762459509456},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s11886-017-0892-4","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T10:53:27Z","timestamp":1501152807000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Myocardial Tissue Engineering for Regenerative Applications"],"prefix":"10.1007","volume":"19","author":[{"given":"Buntaro","family":"Fujita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram-Hubertus","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"892_CR1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016;118:1021\u201340.","journal-title":"Circ Res"},{"key":"892_CR2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"key":"892_CR3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.healun.2016.08.017","volume":"35","author":"LH Lund","year":"2016","unstructured":"Lund LH, Edwards LB, Dipchand AI, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report\u20142016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant. 2016;35:1158\u201369.","journal-title":"J Heart Lung Transplant"},{"key":"892_CR4","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","volume":"34","author":"JK Kirklin","year":"2015","unstructured":"Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015;34:1495\u2013504.","journal-title":"J Heart Lung Transplant"},{"key":"892_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.carpath.2015.02.004","volume":"24","author":"KA Gerbin","year":"2015","unstructured":"Gerbin KA, Murry CE. The winding road to regenerating the human heart. Cardiovasc Pathol. 2015;24:133\u201340.","journal-title":"Cardiovasc Pathol"},{"key":"892_CR6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamacardio.2016.2750","volume":"1","author":"PK Nguyen","year":"2016","unstructured":"Nguyen PK, Neofytou E, Rhee JW, Wu JC. Potential strategies to address the major clinical barriers facing stem cell regenerative therapy for cardiovascular disease: a review. JAMA Cardiol. 2016;1:953\u201362.","journal-title":"JAMA Cardiol"},{"key":"892_CR7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/CIRCRESAHA.113.300216","volume":"113","author":"L Ye","year":"2013","unstructured":"Ye L, Zimmermann WH, Garry DJ, Zhang J. Patching the heart: cardiac repair from within and outside. Circ Res. 2013;113:922\u201332.","journal-title":"Circ Res"},{"key":"892_CR8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCRESAHA.115.306985","volume":"117","author":"J Riegler","year":"2015","unstructured":"Riegler J, Tiburcy M, Ebert A, et al. Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model. Circ Res. 2015;117:720\u201330.","journal-title":"Circ Res"},{"key":"892_CR9","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.116.024145","volume":"135","author":"M Tiburcy","year":"2017","unstructured":"\u2022\u2022 Tiburcy M, Hudson JE, Balfanz P, et al. Defined engineered human myocardium with advanced maturation for applications in heart failure modelling and repair. Circulation. 2017;135:1832\u201347. This study developed a universally applicable protocol for the generation of engineered human myocardium (EHM) under fully defined GMP-compatible conditions from ESC- or iPSC-derived cardiomyocytes and fibroblasts in a collagen type I hydrogel.","journal-title":"Circulation"},{"key":"892_CR10","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","volume":"36","author":"P Menasche","year":"2015","unstructured":"\u2022\u2022 Menasche P, Vanneaux V, Hagege A, et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur Heart J. 2015;36:2011\u20137. This is the first report on the implantation of human ESC-derived cardiac progenitor cell allografts in a fibrin matrix in patients with heart failure.","journal-title":"Eur Heart J"},{"key":"892_CR11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.athoracsur.2007.10.052","volume":"85","author":"JC Chachques","year":"2008","unstructured":"Chachques JC, Trainini JC, Lago N, Cortes-Morichetti M, Schussler O, Carpentier A. Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. Ann Thorac Surg. 2008;85:901\u20138.","journal-title":"Ann Thorac Surg"},{"key":"892_CR12","doi-asserted-by":"crossref","unstructured":"Miyagawa S, Domae K, Yoshikawa Y, et al. Phase I clinical trial of autologous stem cell-sheet transplantation therapy for treating cardiomyopathy. J Am Heart Assoc. 2017;6.","DOI":"10.1161\/JAHA.116.003918"},{"key":"892_CR13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1369-7021(11)70058-X","volume":"14","author":"FJ O\u2019Brien","year":"2011","unstructured":"O\u2019Brien FJ. Biomaterials & scaffolds for tissue engineering. Mater Today. 2011;14:88\u201395.","journal-title":"Mater Today"},{"key":"892_CR14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4939-1047-2_15","volume":"1181","author":"M Tiburcy","year":"2014","unstructured":"Tiburcy M, Meyer T, Soong PL, Zimmermann WH. Collagen-based engineered heart muscle. Methods Mol Biol. 2014;1181:167\u201376.","journal-title":"Methods Mol Biol"},{"key":"892_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4939-1047-2_11","volume":"1181","author":"S Schaaf","year":"2014","unstructured":"Schaaf S, Eder A, Vollert I, Stohr A, Hansen A, Eschenhagen T. Generation of strip-format fibrin-based engineered heart tissue (EHT). Methods Mol Biol. 2014;1181:121\u20139.","journal-title":"Methods Mol Biol"},{"key":"892_CR16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1097-0290(20000405)68:1<106::AID-BIT13>3.0.CO;2-3","volume":"68","author":"WH Zimmermann","year":"2000","unstructured":"Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng. 2000;68:106\u201314.","journal-title":"Biotechnol Bioeng"},{"key":"892_CR17","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1016\/j.biomaterials.2013.04.026","volume":"34","author":"D Zhang","year":"2013","unstructured":"Zhang D, Shadrin IY, Lam J, Xian HQ, Snodgrass HR, Bursac N. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials. 2013;34:5813\u201320.","journal-title":"Biomaterials"},{"key":"892_CR18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/eurheartj\/ehs349","volume":"34","author":"G Kensah","year":"2013","unstructured":"Kensah G, Roa Lara A, Dahlmann J, et al. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur Heart J. 2013;34:1134\u201346.","journal-title":"Eur Heart J"},{"key":"892_CR19","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1093\/eurheartj\/ehs203","volume":"34","author":"K Streckfuss-Bomeke","year":"2013","unstructured":"Streckfuss-Bomeke K, Wolf F, Azizian A, et al. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur Heart J. 2013;34:2618\u201329.","journal-title":"Eur Heart J"},{"key":"892_CR20","doi-asserted-by":"crossref","unstructured":"Soong PL, Tiburcy M, Zimmermann WH. Cardiac differentiation of human embryonic stem cells and their assembly into engineered heart muscle. Curr Protoc Cell Biol. 2012;Chapter 23:Unit23 8.","DOI":"10.1002\/0471143030.cb2308s55"},{"key":"892_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCRESAHA.110.237206","volume":"109","author":"NL Tulloch","year":"2011","unstructured":"Tulloch NL, Muskheli V, Razumova MV, et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res. 2011;109:47\u201359.","journal-title":"Circ Res"},{"key":"892_CR22","doi-asserted-by":"crossref","first-page":"18129","DOI":"10.1073\/pnas.0407817101","volume":"101","author":"M Radisic","year":"2004","unstructured":"Radisic M, Park H, Shing H, et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A. 2004;101:18129\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"892_CR23","doi-asserted-by":"crossref","first-page":"14990","DOI":"10.1073\/pnas.0812242106","volume":"106","author":"T Dvir","year":"2009","unstructured":"Dvir T, Kedem A, Ruvinov E, et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A. 2009;106:14990\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"892_CR24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","volume":"15","author":"L Ye","year":"2014","unstructured":"Ye L, Chang YH, Xiong Q, et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. 2014;15:750\u201361.","journal-title":"Cell Stem Cell"},{"key":"892_CR25","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/nprot.2009.155","volume":"4","author":"W Bian","year":"2009","unstructured":"Bian W, Liau B, Badie N, Bursac N. Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc. 2009;4:1522\u201334.","journal-title":"Nat Protoc"},{"key":"892_CR26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.RES.68.3.734","volume":"68","author":"L Terracio","year":"1991","unstructured":"Terracio L, Rubin K, Gullberg D, et al. Expression of collagen binding integrins during cardiac development and hypertrophy. Circ Res. 1991;68:734\u201344.","journal-title":"Circ Res"},{"key":"892_CR27","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0735-1097(89)90360-4","volume":"13","author":"KT Weber","year":"1989","unstructured":"Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol. 1989;13:1637\u201352.","journal-title":"J Am Coll Cardiol"},{"key":"892_CR28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCRESAHA.109.211458","volume":"107","author":"A Hansen","year":"2010","unstructured":"Hansen A, Eder A, Bonstrup M, et al. Development of a drug screening platform based on engineered heart tissue. Circ Res. 2010;107:35\u201344.","journal-title":"Circ Res"},{"key":"892_CR29","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCRESAHA.111.251843","volume":"109","author":"M Tiburcy","year":"2011","unstructured":"Tiburcy M, Didie M, Boy O, et al. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circ Res. 2011;109:1105\u201314.","journal-title":"Circ Res"},{"key":"892_CR30","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nmat2316","volume":"7","author":"GC Engelmayr Jr","year":"2008","unstructured":"Engelmayr GC Jr, Cheng M, Bettinger CJ, Borenstein JT, Langer R, Freed LE. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater. 2008;7:1003\u201310.","journal-title":"Nat Mater"},{"key":"892_CR31","doi-asserted-by":"crossref","first-page":"385102","DOI":"10.1088\/0957-4484\/23\/38\/385102","volume":"23","author":"R Ravichandran","year":"2012","unstructured":"Ravichandran R, Venugopal JR, Sundarrajan S, Mukherjee S, Sridhar R, Ramakrishna S. Minimally invasive injectable short nanofibers of poly (glycerol sebacate) for cardiac tissue engineering. Nanotechnology. 2012;23:385102.","journal-title":"Nanotechnology"},{"key":"892_CR32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCRESAHA.115.306874","volume":"118","author":"JP Guyette","year":"2016","unstructured":"Guyette JP, Charest JM, Mills RW, et al. Bioengineering human myocardium on native extracellular matrix. Circ Res. 2016;118:56\u201372.","journal-title":"Circ Res"},{"key":"892_CR33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm1684","volume":"14","author":"HC Ott","year":"2008","unstructured":"Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature\u2019s platform to engineer a bioartificial heart. Nat Med. 2008;14:213\u201321.","journal-title":"Nat Med"},{"key":"892_CR34","first-page":"799","volume":"20","author":"Z Vukadinovic-Nikolic","year":"2014","unstructured":"Vukadinovic-Nikolic Z, Andree B, Dorfman SE, et al. Generation of bioartificial heart tissue by combining a three-dimensional gel-based cardiac construct with decellularized small intestinal submucosa. Tissue Eng A. 2014;20:799\u2013809.","journal-title":"Tissue Eng A"},{"key":"892_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.02.011","volume":"125","author":"JR Gershlak","year":"2017","unstructured":"Gershlak JR, Hernandez S, Fontana G, et al. Crossing kingdoms: using decellularized plants as perfusable tissue engineering scaffolds. Biomaterials. 2017;125:13\u201322.","journal-title":"Biomaterials"},{"key":"892_CR36","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1161\/hh0302.105722","volume":"90","author":"T Shimizu","year":"2002","unstructured":"Shimizu T, Yamato M, Isoi Y, et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res. 2002;90:e40.","journal-title":"Circ Res"},{"key":"892_CR37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2220\/biomedres.36.11","volume":"36","author":"Y Otsuki","year":"2015","unstructured":"Otsuki Y, Nakamura Y, Harada S, et al. Adipose stem cell sheets improved cardiac function in the rat myocardial infarction, but did not alter cardiac contractile responses to beta-adrenergic stimulation. Biomed Res. 2015;36:11\u20139.","journal-title":"Biomed Res"},{"key":"892_CR38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/TP.0000000000001014","volume":"100","author":"T Shirasaka","year":"2016","unstructured":"Shirasaka T, Miyagawa S, Fukushima S, et al. Skeletal myoblast cell sheet implantation ameliorates both systolic and diastolic cardiac performance in canine dilated cardiomyopathy model. Transplantation. 2016;100:295\u2013302.","journal-title":"Transplantation"},{"key":"892_CR39","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1096\/fj.05-4715fje","volume":"20","author":"T Shimizu","year":"2006","unstructured":"Shimizu T, Sekine H, Yang J, et al. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 2006;20:708\u201310.","journal-title":"FASEB J"},{"key":"892_CR40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm1394","volume":"12","author":"WH Zimmermann","year":"2006","unstructured":"Zimmermann WH, Melnychenko I, Wasmeier G, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006;12:452\u20138.","journal-title":"Nat Med"},{"key":"892_CR41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamacardio.2016.2225","volume":"1","author":"PK Nguyen","year":"2016","unstructured":"Nguyen PK, Rhee JW, Wu JC. Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review. JAMA Cardiol. 2016;1:831\u201341.","journal-title":"JAMA Cardiol"},{"key":"892_CR42","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","volume":"2","author":"AG Ibrahim","year":"2014","unstructured":"Ibrahim AG, Cheng K, Marban E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep. 2014;2:606\u201319.","journal-title":"Stem Cell Rep"},{"key":"892_CR43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature15372","volume":"525","author":"K Wei","year":"2015","unstructured":"Wei K, Serpooshan V, Hurtado C, et al. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart. Nature. 2015;525:479\u201385.","journal-title":"Nature"},{"key":"892_CR44","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/eurheartj\/ehv259","volume":"36","author":"SD Anker","year":"2015","unstructured":"Anker SD, Coats AJ, Cristian G, et al. A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial). Eur Heart J. 2015;36:2297\u2013309.","journal-title":"Eur Heart J"},{"key":"892_CR45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.scr.2015.08.002","volume":"15","author":"VC Chen","year":"2015","unstructured":"Chen VC, Ye J, Shukla P, et al. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. Stem Cell Res. 2015;15:365\u201375.","journal-title":"Stem Cell Res"},{"key":"892_CR46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.addr.2015.11.016","volume":"96","author":"H Kempf","year":"2016","unstructured":"Kempf H, Andree B, Zweigerdt R. Large-scale production of human pluripotent stem cell derived cardiomyocytes. Adv Drug Deliv Rev. 2016;96:18\u201330.","journal-title":"Adv Drug Deliv Rev"},{"key":"892_CR47","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1203\/PDR.0b013e318199093c","volume":"65","author":"RF Wiegerinck","year":"2009","unstructured":"Wiegerinck RF, Cojoc A, Zeidenweber CM, et al. Force frequency relationship of the human ventricle increases during early postnatal development. Pediatr Res. 2009;65:414\u20139.","journal-title":"Pediatr Res"},{"key":"892_CR48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1096\/fasebj.11.8.9240969","volume":"11","author":"T Eschenhagen","year":"1997","unstructured":"Eschenhagen T, Fink C, Remmers U, et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 1997;11:683\u201394.","journal-title":"FASEB J"},{"key":"892_CR49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/hh0202.103644","volume":"90","author":"WH Zimmermann","year":"2002","unstructured":"Zimmermann WH, Schneiderbanger K, Schubert P, et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res. 2002;90:223\u201330.","journal-title":"Circ Res"},{"key":"892_CR50","doi-asserted-by":"crossref","first-page":"I72","DOI":"10.1161\/CIRCULATIONAHA.105.001560","volume":"114","author":"H Naito","year":"2006","unstructured":"Naito H, Melnychenko I, Didie M, et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation. 2006;114:I72\u20138.","journal-title":"Circulation"},{"key":"892_CR51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1024725818835","volume":"8","author":"WH Zimmermann","year":"2003","unstructured":"Zimmermann WH, Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Fail Rev. 2003;8:259\u201369.","journal-title":"Heart Fail Rev"},{"key":"892_CR52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.RES.0000257776.05673.ff","volume":"100","author":"O Caspi","year":"2007","unstructured":"Caspi O, Lesman A, Basevitch Y, et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res. 2007;100:263\u201372.","journal-title":"Circ Res"},{"key":"892_CR53","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI66854","volume":"123","author":"M Didi\u00e9","year":"2013","unstructured":"Didi\u00e9 M, Christalla P, Rubart M, et al. Parthenogenetic stem cells for tissue-engineered heart repair. J Clin Invest. 2013;123:1285\u201398.","journal-title":"J Clin Invest"},{"key":"892_CR54","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI66854","volume":"123","author":"M Didie","year":"2013","unstructured":"Didie M, Christalla P, Rubart M, et al. Parthenogenetic stem cells for tissue-engineered heart repair. J Clin Invest. 2013;123:1285\u201398.","journal-title":"J Clin Invest"},{"key":"892_CR55","doi-asserted-by":"crossref","first-page":"363ra148","DOI":"10.1126\/scitranslmed.aaf8781","volume":"8","author":"F Weinberger","year":"2016","unstructured":"Weinberger F, Breckwoldt K, Pecha S, et al. Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells. Sci Transl Med. 2016;8:363ra148.","journal-title":"Sci Transl Med"},{"key":"892_CR56","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1161\/CIRCULATIONAHA.111.084343","volume":"126","author":"M Kawamura","year":"2012","unstructured":"Kawamura M, Miyagawa S, Miki K, et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation. 2012;126:S29\u201337.","journal-title":"Circulation"},{"key":"892_CR57","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biomaterials.2015.03.055","volume":"60","author":"AF Godier-Furnemont","year":"2015","unstructured":"Godier-Furnemont AF, Tiburcy M, Wagner E, et al. Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. Biomaterials. 2015;60:82\u201391.","journal-title":"Biomaterials"},{"key":"892_CR58","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","volume":"113","author":"GP Meyer","year":"2006","unstructured":"Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months\u2019 follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 2006;113:1287\u201394.","journal-title":"Circulation"},{"key":"892_CR59","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","volume":"306","author":"JH Traverse","year":"2011","unstructured":"Traverse JH, Henry TD, Ellis SG, et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011;306:2110\u20139.","journal-title":"JAMA"},{"key":"892_CR60","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","volume":"308","author":"JH Traverse","year":"2012","unstructured":"Traverse JH, Henry TD, Pepine CJ, et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA. 2012;308:2380\u20139.","journal-title":"JAMA"},{"key":"892_CR61","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308:2369\u201379.","journal-title":"JAMA"},{"key":"892_CR62","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1161\/01.CIR.0000043246.74879.CD","volume":"106","author":"B Assmus","year":"2002","unstructured":"Assmus B, Schachinger V, Teupe C, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 2002;106:3009\u201317.","journal-title":"Circulation"},{"key":"892_CR63","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","volume":"378","author":"R Bolli","year":"2011","unstructured":"Bolli R, Chugh AR, D\u2019Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378:1847\u201357.","journal-title":"Lancet"},{"key":"892_CR64","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","volume":"63","author":"K Malliaras","year":"2014","unstructured":"Malliaras K, Makkar RR, Smith RR, et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol. 2014;63:110\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"892_CR65","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3727\/096368907783338217","volume":"16","author":"JC Chachques","year":"2007","unstructured":"Chachques JC, Trainini JC, Lago N, et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplant. 2007;16:927\u201334.","journal-title":"Cell Transplant"},{"key":"892_CR66","doi-asserted-by":"crossref","unstructured":"Homma J, Sekine H, Matsuura K, Yamato M, Shimizu T. Myoblast cell sheet transplantation enhances the endogenous regenerative abilities of infant hearts in rats with myocardial infarction. J Tissue Eng Regen Med. 2015.","DOI":"10.1002\/term.2087"},{"key":"892_CR67","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1253\/circj.CJ-15-0243","volume":"79","author":"Y Sawa","year":"2015","unstructured":"Sawa Y, Yoshikawa Y, Toda K, et al. Safety and efficacy of autologous skeletal myoblast sheets (TCD-51073) for the treatment of severe chronic heart failure due to ischemic heart disease. Circ J. 2015;79:991\u20139.","journal-title":"Circ J"},{"key":"892_CR68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10047-015-0862-9","volume":"19","author":"T Imamura","year":"2016","unstructured":"Imamura T, Kinugawa K, Sakata Y, et al. Improved clinical course of autologous skeletal myoblast sheet (TCD-51073) transplantation when compared to a propensity score-matched cardiac resynchronization therapy population. J Artif Organs. 2016;19:80\u20136.","journal-title":"J Artif Organs"},{"key":"892_CR69","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0003-4975(98)01197-7","volume":"67","author":"BZ Atkins","year":"1999","unstructured":"Atkins BZ, Lewis CW, Kraus WE, Hutcheson KA, Glower DD, Taylor DA. Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells in situ. Ann Thorac Surg. 1999;67:124\u20139.","journal-title":"Ann Thorac Surg"},{"key":"892_CR70","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nm0898-929","volume":"4","author":"DA Taylor","year":"1998","unstructured":"Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998;4:929\u201333.","journal-title":"Nat Med"},{"key":"892_CR71","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","volume":"117","author":"P Menasche","year":"2008","unstructured":"Menasche P, Alfieri O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008;117:1189\u2013200.","journal-title":"Circulation"},{"key":"892_CR72","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1161\/CIRCULATIONAHA.109.927293","volume":"122","author":"A Bel","year":"2010","unstructured":"Bel A, Planat-Bernard V, Saito A, et al. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation. 2010;122:S118\u201323.","journal-title":"Circulation"},{"key":"892_CR73","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI40120","volume":"120","author":"G Blin","year":"2010","unstructured":"Blin G, Nury D, Stefanovic S, et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest. 2010;120:1125\u201339.","journal-title":"J Clin Invest"},{"key":"892_CR74","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/107632704323061762","volume":"10","author":"KL Christman","year":"2004","unstructured":"Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 2004;10:403\u20139.","journal-title":"Tissue Eng"},{"key":"892_CR75","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jacc.2005.04.056","volume":"46","author":"W Dai","year":"2005","unstructured":"Dai W, Wold LE, Dow JS, Kloner RA. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol. 2005;46:714\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"892_CR76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2016.05.053","volume":"68","author":"SV Rao","year":"2016","unstructured":"Rao SV, Zeymer U, Douglas PS, et al. Bioabsorbable intracoronary matrix for prevention of ventricular remodeling after myocardial infarction. J Am Coll Cardiol. 2016;68:715\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"892_CR77","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ejhf.449","volume":"18","author":"DL Mann","year":"2016","unstructured":"Mann DL, Lee RJ, Coats AJ, et al. One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure. Eur J Heart Fail. 2016;18:314\u201325.","journal-title":"Eur J Heart Fail"},{"key":"892_CR78","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.healun.2015.08.003","volume":"34","author":"LH Lund","year":"2015","unstructured":"Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report\u20142015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34:1244\u201354.","journal-title":"J Heart Lung Transplant"},{"key":"892_CR79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","volume":"11","author":"CJ Taylor","year":"2012","unstructured":"\u2022 Taylor CJ, Peacock S, Chaudhry AN, Bradley JA, Bolton EM. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell. 2012;11:147\u201352. Important overview on the concept and limitations of the identification und use of HLA-homozygous iPSC-allografts.","journal-title":"Cell Stem Cell"},{"key":"892_CR80","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5966\/sctm.2013-0127","volume":"3","author":"B Daughtry","year":"2014","unstructured":"Daughtry B, Mitalipov S. Concise review: parthenote stem cells for regenerative medicine: genetic, epigenetic, and developmental features. Stem Cells Transl Med. 2014;3:290\u20138.","journal-title":"Stem Cells Transl Med"},{"key":"892_CR81","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8:409\u201312.","journal-title":"Nat Methods"},{"key":"892_CR82","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1172\/JCI80575","volume":"125","author":"E Neofytou","year":"2015","unstructured":"Neofytou E, O\u2019Brien CG, Couture LA, Wu JC. Hurdles to clinical translation of human induced pluripotent stem cells. J Clin Invest. 2015;125:2551\u20137.","journal-title":"J Clin Invest"},{"key":"892_CR83","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","volume":"510","author":"JJ Chong","year":"2014","unstructured":"Chong JJ, Yang X, Don CW, et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. 2014;510:273\u20137.","journal-title":"Nature"},{"key":"892_CR84","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1399-0039.2010.01466.x","volume":"75","author":"SG Marsh","year":"2010","unstructured":"Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291\u2013455.","journal-title":"Tissue Antigens"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-017-0892-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0892-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0892-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T17:47:44Z","timestamp":1569952064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-017-0892-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["892"],"URL":"https:\/\/doi.org\/10.1007\/s11886-017-0892-4","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]},"article-number":"78"}}